Abstract:Background: Recent studies have highlighted the significant role of the NF-κB signaling pathway in the initiation and progression of cancer. Furthermore, long noncoding RNAs (lncRNAs) have been identified as pivotal regulators in sustaining the NF-κB signaling pathway's functionality. Despite these findings, the underlying molecular mechanisms through which lncRNAs influence the NF-κB pathway remain largely unexplored. Methods: Bioinformatic analyses were utilized to investigate the differential expression and prognostic significance of XTP6. The functional roles of XTP6 were further elucidated through both in vitro and in vivo experimental approaches. To estimate the interaction between XTP6 and NDH2, RNA pulldown and RNA Immunoprecipitation (RIP) assays were conducted. The connection between XTP6 and the IκBα promoter was examined using Chromatin Isolation by RNA Purification (ChIRP) assays. Additionally, Chromatin Immunoprecipitation (ChIP) assays were implemented to analyze the binding affinity of c-myc to the XTP6 promoter, providing insights into the regulatory mechanisms at play. Results: XTP6 was remarkedly upregulated in glioblastoma multiforme (GBM) tissues and was connected with adverse prognosis in GBM patients. Our investigations revealed that XTP6 can facilitate the malignant progression of GBM both in vitro and in vivo. Additionally, XTP6 downregulated IκBα expression by recruiting NDH2 to the IκBα promoter, which resulted in elevated levels of H3K27me3, thereby reducing the transcriptional activity of IκBα. Moreover, the progression of GBM was further driven by the c-myc-mediated upregulation of XTP6, establishing a positive feedback loop with IκBα that perpetuated the activation of the NF-κB signaling pathway. Notably, the application of an inhibitor targeting the NF-κB signaling pathway effectively inhibited the continuous activation induced by XTP6, leading to a significant reduction in tumor formation in vivo. Conclusion: The results reveal that XTP6 unveils an innovative epigenetic mechanism instrumental in the sustained activation of the NF-κB signaling pathway, suggesting a promising therapeutic target for the treatment of GBM.

Extracellular vesicles-transferred SBSN drives glioma aggressiveness by activating NF-κB via ANXA1-dependent ubiquitination of NEMO

Overexpression of SHCBP1 Promotes Migration and Invasion in Gliomas by Activating the NF‐κB Signaling Pathway

Extracellular vesicles derived from glioblastoma promote proliferation and migration of neural progenitor cells via PI3K-Akt pathway

Extracellular Vesicles Derived from Central Nervous System Suppresses Antitumor Immunity

Glioblastoma Extracellular Vesicles Induce the Tumour-Promoting Transformation of Neural Stem Cells

UBE2S facilitates glioblastoma progression through activation of the NF-κB pathway via attenuating K11-linked ubiquitination of AKIP1

SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway

Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway

Positive feedback loop of c-myc/XTP6/NDH2/NF-κB to promote malignant progression in glioblastoma

Immunomodulatory effects of extracellular vesicles in glioblastoma

SAE1 Promotes Human Glioma Progression Through Activating AKT SUMOylation-mediated Signaling Pathways

Exosomal circRNA 0001445 promotes glioma progression through miRNA-127-5p/SNX5 pathway

SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-κB pathway

Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment

Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis

Glioma-Stem-Cell-Derived Exosomes Remodeled Glioma-Associated Macrophage via NEAT1/miR-125a/STAT3 Pathway

AEG-1/MTDH-activated Autophagy Enhances Human Malignant Glioma Susceptibility to TGF-β1-triggered Epithelial-Mesenchymal Transition

Role of Tumor-Derived Extracellular Vesicles in Glioblastoma

NQO1 Drives Glioblastoma Cell Aggressiveness Through EMT Induction Via the PI3K/Akt/mTOR/Snail Pathway

Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-B/IL-6/STAT3 and JNK/PTX3 pathways

Tumor-derived extracellular vesicles: how they mediate glioma immunosuppression